Literature DB >> 31601093

Inhibition of miR-34a-5p protected myocardial ischemia reperfusion injury-induced apoptosis and reactive oxygen species accumulation through regulation of Notch Receptor 1 signaling.

Zheng Wang1, Zhan Wang2, Tiezhong Wang1, Jiayang Yuan1, Xuechen Wang2, Zhiguo Zhang2.   

Abstract

Myocardial ischemia-reperfusion (I/R) injury is leading cause of death worldwide. miR-34a-5p was up-regulated in myocardial ischemia-reperfusion injury rats. We aim to explore how miR-34a-5p inhibition protected myocardium against I/R injury in both cell and animal models. In vivo rat and in vitro cell model were firstly constructed. quantitative real-time polymerase chain reaction was employed to investigate expression of miR-34a-5p and its target genes. Functional assays were conducted to detect the impact of miR-34a-5p on myocardial I/R injury. Enzyme-linked immunosorbent assay was performed to validate the expression levels of marker proteins of ischemia-reperfusion I/R-induced myocardial injury. MTT was performed to assess the cell viability and flow cytometry was utilized to detect cell apoptosis and reactive oxygen species accumulation. The interaction between miR-34a-5p and Notch Receptor 1 were also examined through luciferase reporter assay. miR-34a-5p was up-regulated post-reperfusion at rat myocardium. miR-34a-5p inhibitor attenuated myocardial ischemia-reperfusion injury, as shown by decreasing apoptosis rate, reducing infarct size and reactive oxygen species accumulation. In in vitro cell model, miR-34a-5p inhibitor also promoted cell proliferation, inhibited cell apoptosis and reactive oxygen species accumulation through targeting Notch Receptor 1 signaling. Our results revealed that miR-34a-5p knocking down attenuated myocardial I/R injury by promoting Notch Receptor 1 signaling-mediated inhibition of reactive oxygen species accumulation and cell apoptosis. Hence, miR-34a-5p might be a potential target for treatment of myocardial ischemia-reperfusion injury. ©2019 Wang et al. Published by IMR press. All rights reserved.

Entities:  

Keywords:  MiR-34a-5p; Notch Receptor 1; apoptosis; ischemia-reperfusion injury; reactive oxygen species

Year:  2019        PMID: 31601093     DOI: 10.31083/j.rcm.2019.03.545

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  9 in total

1.  hsa-miR-34a-5p Ameliorates Hepatic Ischemia/Reperfusion Injury Via Targeting HNF4α.

Authors:  Xiaoqiang Zheng; Gang Wang; Jiang Yuan; Nuoya Li; Biaolei Yan; Jinlong Yan; Yanling Sheng
Journal:  Turk J Gastroenterol       Date:  2022-07       Impact factor: 1.555

2.  CD146+Mesenchymal stem cells treatment improves vascularization, muscle contraction and VEGF expression, and reduces apoptosis in rat ischemic hind limb.

Authors:  Tao Chen; Bo Ye; Jing Tan; Haifeng Yang; Faming He; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2021-04-21       Impact factor: 6.100

3.  Circ-LRP1B functions as a competing endogenous RNA to regulate proliferation, apoptosis and oxidative stress of LPS-induced human C28/I2 chondrocytes.

Authors:  Sixiao Zhang; Jian Luo; Shuai Zeng
Journal:  J Bioenerg Biomembr       Date:  2022-03-10       Impact factor: 3.853

4.  Chinese Herbal Formulas Miao-Yi-Ai-Tang Inhibits the Proliferation and Migration of Lung Cancer Cells through Targeting β-Catenin/AXIN and Presents Synergistic Effect with Cisplatin Suppressing Lung Cancer.

Authors:  Bo Li; Wei Zhang; Tao Tan; Wei Liu; Xian Luo; Jun Zhang; Yi Yang; Ruogu Li; Zhengxing Ge
Journal:  Biomed Res Int       Date:  2020-01-16       Impact factor: 3.411

5.  MiR-874-3p inhibits osteogenic differentiation of human periodontal ligament fibroblasts through regulating Wnt/β-catenin pathway.

Authors:  Shengzhang Song; Zhuanjun Yan; Wangxi Wu
Journal:  J Dent Sci       Date:  2021-04-07       Impact factor: 2.080

Review 6.  Mitochondrial Dynamics: Pathogenesis and Therapeutic Targets of Vascular Diseases.

Authors:  Yi Luan; Kai-Di Ren; Ying Luan; Xing Chen; Yang Yang
Journal:  Front Cardiovasc Med       Date:  2021-12-06

Review 7.  Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases.

Authors:  Cun-Cun Hua; Xin-Ming Liu; Li-Rong Liang; Le-Feng Wang; Jiu-Chang Zhong
Journal:  Front Cardiovasc Med       Date:  2022-01-27

8.  MicroRNA-34a Promotes Ischemia-Induced Cardiomyocytes Apoptosis through Targeting Notch1.

Authors:  Jialin Pan; Lili Zhou; Cong Lin; Weihao Xue; Peng Chen; Jiafeng Lin
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-28       Impact factor: 2.629

9.  Analysis of the miRNA-mRNA Regulatory Network Reveals the Biomarker Genes in the Progression of Myocardial Ischemic Reperfusion.

Authors:  Nini Li; Qing Chen
Journal:  J Healthc Eng       Date:  2022-04-13       Impact factor: 3.822

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.